Back to Search
Start Over
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease
- Source :
- Science Translational Medicine; June 2022, Vol. 14 Issue: 648
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 19466234 and 19466242
- Volume :
- 14
- Issue :
- 648
- Database :
- Supplemental Index
- Journal :
- Science Translational Medicine
- Publication Type :
- Periodical
- Accession number :
- ejs59887677
- Full Text :
- https://doi.org/10.1126/scitranslmed.abj2658